Congress Asset Management CO Pfizer Inc Transaction History

Congress Asset Management CO

$14.3 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$32.09 - $37.51 $77,368 - $90,436	-2,411 Reduced 25.56%	7,023 $232,000
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $3,214 - $3,719	-89 Reduced 0.93%	9,434 $346,000
Q1 2023 Apr 21, 2023	BUY	$39.39 - $51.28 $4,687 - $6,102	119 Added 1.27%	9,523 $388,000
Q4 2022 Jan 18, 2023	BUY	$41.75 - $54.5 $626 - $817	15 Added 0.16%	9,404 $0
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $57,281 - $69,926	1,309 Added 16.2%	9,389 $411,000
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $651 - $772	14 Added 0.17%	8,080 $424,000
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $15,234 - $18,877	-333 Reduced 3.96%	8,066 $418,000
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $53,509 - $79,318	-1,295 Reduced 13.36%	8,399 $496,000
Q3 2021 Nov 08, 2021	BUY	$39.25 - $50.42 $4,670 - $5,999	119 Added 1.24%	9,694 $417,000
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $25,998 - $29,452	-724 Reduced 7.03%	9,575 $375,000
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $2,813 - $3,172	84 Added 0.82%	10,299 $373,000
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $34,875 - $44,347	1,042 Added 11.36%	10,215 $376,000
Q3 2020 Nov 03, 2020	SELL	$31.75 - $37.25 $11,874 - $13,931	-374 Reduced 3.92%	9,173 $337,000
Q2 2020 Jul 23, 2020	BUY	$30.12 - $36.54 $12,048 - $14,616	400 Added 4.37%	9,547 $312,000
Q1 2020 Apr 21, 2020	SELL	$27.03 - $38.62 $9,703 - $13,864	-359 Reduced 3.78%	9,147 $299,000
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $68,868 - $78,157	-2,092 Reduced 18.04%	9,506 $372,000
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $2,566 - $3,328	-79 Reduced 0.68%	11,598 $417,000
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $4,807 - $5,397	-130 Reduced 1.1%	11,677 $506,000
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $53,550 - $58,833	-1,428 Reduced 10.79%	11,807 $501,000
Q4 2018 Jan 25, 2019	BUY	$38.47 - $43.86 $9,771 - $11,140	254 Added 1.96%	13,235 $578,000
Q3 2018 Oct 26, 2018	BUY	$34.47 - $41.81 $15,166 - $18,396	440 Added 3.51%	12,981 $572,000
Q2 2018 Jul 25, 2018	SELL	$32.98 - $35.16 $50,063 - $53,372	-1,518 Reduced 10.8%	12,541 $455,000
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $28,336 - $32,873	888 Added 6.74%	14,059 $499,000
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $3,159 - $3,352	95 Added 0.73%	13,171 $477,000
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $405,356 - $446,545	13,076	13,076 $467,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.4 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.1 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.53 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.41 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account